Synthetic DNA of Unlimited Length
Delivered in days. Accurate and affordable.
Ribbon Biolabs is developing a revolutionary technology for the fast and efficient automated synthesis of DNA to enable the new wave of biotechnological innovation.
Through our unique technology combining biochemistry, computing and automation, Ribbon Biolabs will make complex DNA accessible and affordable for our customers in the biotech industry and in academia.
Ribbon Biolabs wants to place itself as the key player in synthetic DNA of any complexity, empowering its customers to tackle challenges and develop products that today are only possible in our imagination.
Accelerate your R&D
We make synthetic DNA of any length available for your innovative application in biotechnology, biopharma or academic research. Whether you need long DNA molecules or variant libraries – with our radically novel technology, you will have it at hand in only days and at affordable cost.
Invest in the future of biotech
Synthetic biology is not only one of the most rapidly growing markets, it also has disruptive potential. The major bottleneck for its advance is the availability of synthetic DNA. Ribbon Biolabs’ cost-efficient platform for automated high-throughput production of long and complex DNA molecules will help to overcome this impediment.
Invest in the future of biotech
Synthetic biology is one of the most rapidly growing markets and has disruptive potential for many industries. The major bottleneck for its advance is the availability of synthetic DNA. Ribbon Biolabs’ platform for automated high-throughput production of long DNA will help to overcome this impediment.
.
Join our team
As an early-stage startup company with ambitious growth plans we are always looking for talented people to expand our diverse and interdisciplinary team. Besides a workplace in one of the most liveable cities of the world and a new state-of-the art laboratory we offer the opportunity to grow with the company.
News and Events
Sep 11, 2020
Meet us (virtually) at the 12th Annual ÖGMBT Meeting
Meet us on September 23 at the Life Science Career Fair! The Annual ÖGMBT Meeting is the melting pot of the Austrian Life Science Community …
Jun 6, 2020
Funding the future: The race for a vaccine
Ribbon Biolabs’ CEO is discussing the funds required to develop a coronavirus vaccine in an online special event organized by the online magazine Metropole …
Apr 12, 2019
Ribbon Biolabs is ‘Startup of the Week’ in labiotech.eu
We are honored to be featured on labiotech.eu as ‘Startup of the Week’. Thanks to Jonathan Smith for the comprehensive article …
Twitter Feed
Tribute & greetings to all #WomeninScience #WomeninSTEM on today’s occasion of #InternationalDayofWomenandGirlsinScience” 👩🔬 🌍 Let’s make this a sustainable & healthy place together. #science #health #sustainability #biotech
Jetzt live, PK zu "40 Millionen Euro für Gründungen aus der Wissenschaft", @ist_cube increases venture fund for founders from science 10-fold in cooperation with European Investment Fund EIF and 25 other investors @EquityTecnet http://streamers.at/tecnet/ https://ist-cube.com/more-than-40-million-euros-in-fresh-capital-for-life-science-and-tech-spin-offs/
Manufacturing #antibody treatments is a promising avenue for a range of illnesses, but the process can take up to several months 😳
@ribbonbiolabs, a #biotech company from 🇦🇹, plans to do it in hours ⏳
➡️ http://bit.ly/EU_MiChomAbs
#EUresearch
To all my twitter friends: please help us reach as many women as we can in this initiative with @LunaDNA_. We are trying to identify and redefine priorities in women's health research!
Influence the Future of Women’s Health
With the help of women like you, we can drive scientific discovery and amplify the deserving voices in health.
learn.lunadna.com
“Motivation to create impact in synthetic biology”
Short video on the entrepreneurial ecosystem at IST Park, featuring Ribbon Biolabs.
@ist_cube
@ISTAustria
@valanxbio
https://fb.watch/1OHRWTLiT3/